What's Included?
- Includes Prenatalsafe 5
- Provides an overview of All 24 Chromosomes.
- Including;
- Rare Autosomal Aneuploidies
- Sex Chromosomes
- Trisomy 9
- Trisomy 16
- Gender Determination (optional)
Prenatalsafe Karyo includes everything in PrenatalSafe 5 but goes further to offer screening of all 24 chromosomes for Rare autosomal aneuploidies, deletions and duplications. You can have peace of mind knowing that you have valuable information about your growing baby's health
This test includes screening for Trisomy 9: which is a chromosomal condition where the vast majority result in miscarriage in the 1st trimester.
This test includes screening for Trisomy 16: which is the most commonly occurring autosomal trisomy seen in first trimester miscarriages. Sadly, of all trisomy’s, 16 seems to occur in approximately one percent of all pregnancies. and accounting for around 16 % of miscarriages.
This test uses next-generation sequencing (NGS) to bring a Whole Genome Sequencing (WGS) approach to NIPT, expanding test options beyond chromosomes 21, 18, and 13 to include rare autosomal aneuploidies (RAAs), sex chromosome aneuploidies (SCAs). Rare autosomal aneuploidies (RAAs) involve all autosomal chromosomes other than 21, 18, or 13. The most common RAAs detected involve aneuploidies 7, 16, 15, and 22, while aneuploidies involving other chromosomes are relatively rare. Notably, the frequency of RAAs and the proportion of abnormal pregnancy outcomes in these cases largely vary .
This test is suitable for single and *twin pregnancies
*Only the presence or absence of the Y chromosome can be reported in twins.
Results from 10 Working Days. Processed within the EU.
- Choosing a selection results in a full page refresh.